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Abstract
Atlantic salmon (Salmo salar) possess enzymes required for the endogenous biosynthesis of n-3 long-chain PUFA (LC-PUFA), EPA and DHA,
from α-linolenic acid (ALA). Linoleic acid (LA) competes with ALA for LC-PUFA biosynthesis enzymes leading to the production of n-6 LC-PUFA,
including arachidonic acid (ARA). We aimed to quantify the endogenous production of EPA and DHA from ALA in salmon fed from first feeding
on diets that contain no EPA and DHA and to determine the influence of dietary LA and ALA:LA ratio on LC-PUFA production. Salmon were fed
from first feeding for 22 weeks with three diets formulated with linseed and sunflower oils to provide ALA:LA ratios of approximately 3:1, 1:1 and
1:3. Endogenous production of n-3 LC-PUFA was 5·9, 4·4 and 2·8 mg per g fish and that of n-6 LC-PUFA was 0·2, 0·5 and 1·4 mg per g fish in
salmon fed diets with ALA:LA ratios of 3:1, 1:1 and 1:3, respectively. The ratio of n-3:n-6 LC-PUFA production decreased from 27·4 to 2·0, and
DHA:EPA ratio increased and EPA:ARA and DHA:ARA ratios decreased, as dietary ALA:LA ratio decreased. In conclusion, with a dietary ALA:LA
ratio of 1, salmon fry/parr produced about 28 μgn-3 LC-PUFA per g fish per d, with a DHA:EPA ratio of 3·4. Production ofn-3 LC-PUFA exceeded
that ofn-6 LC-PUFA by almost 9-fold. Reducing the dietary ALA:LA ratio reducedn-3 LC-PUFA production and EPA:ARA andDHA:ARA ratios but
increased n-6 LC-PUFA production and DHA:EPA ratio.
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Then-3 long-chain (LC) PUFA, EPA (20 : 5n-3) andDHA (22 : 6n-3)
are recognised as being key essential nutrients in the human diet,
providing a range of health benefits through their molecular,
cellular and physiological actions(1,2). While n-3 LC-PUFA have
physiological functions in their own right as key components
of cellular membranes(3) and regulators of gene expression(4),
many effects are dependent upon their antagonism of n-6
PUFA, especially arachidonic acid (ARA, 20 : 4n-6), metabo-
lism(5). Specifically, both EPA and DHA are precursors of eicosa-
noids and other highly biologically active derivatives that have
important roles in blood homeostasis and the regulation of
inflammation, which help to mitigate the pro-inflammatory
effects of the high and imbalanced dietary n-6 PUFA content
of the Western-type, industrialised diet(6–9). Thus, dietary n-3
LC-PUFA are critical in promoting neural development and
function(10,11) and have beneficial impacts on several patho-
logical conditions including CVD, certain inflammatory diseases
and some cancers(12–15).
Fish and seafood are the major dietary sources of n-3 LC-
PUFA with the so-called ‘oily’ fish such as Atlantic salmon
(Salmo salar), which being the best in delivering a physiologi-
cally effective dose to human consumers(16–18). This is largely
due to the primary production of n-3 LC-PUFA, and it being
almost exclusively of aquatic origin and thus marine food chains
are rich in EPA and DHA with fish accumulating them from their
diet(19–21). However, global fisheries are at maximum levels of
Abbreviations: aco, acyl CoA oxidase; ALA, α-linolenic acid; ARA, arachidonic acid; cDNA, complementary DNA; EFA, essential fatty acid; elovl2, fatty acyl elon-
gase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty acyl elongase isoform b; EU, European Union; fads2d5, Δ-5 fatty acyl desaturase; fads2d6, Δ-6 fatty
acyl desaturase; FAME, fatty acid methyl esters; fas, fatty acid synthase; FM, fishmeal; FO, fish oil; LA, linoleic acid; LC, long-chain; PL, phospholipids; ppara,
peroxisome proliferator-activated receptor α; pparg, peroxisome proliferator-activated receptor γ; RT, reverse transcription; srebp1, sterol regulatory element bind-
ing protein 1; srebp2, sterol regulatory element-binding protein 2; UoS, University of Stirling; VO, vegetable oil.
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exploitation, and production has stagnated for almost a quarter
of a century, with the increasing demand of the burgeoning
human population for fish and seafood being met by
aquaculture(22). While over 50 % of all fish and seafood is derived
from aquaculture(22), the n-3 LC-PUFA content of farmed
produce could only be guaranteed by basing feeds on fishmeal
(FM) and fish oil (FO), which are derived from marine fisheries
that are also at sustainable limits(23). Therefore, FO and FM are
finite resources on an annual basis, and their supply would limit
aquaculture growth if they were not increasingly replaced in
aqua feeds by plant meals and vegetable oils (VO) derived
from agriculture(24–26). However, terrestrial plants do not pro-
duce LC-PUFA and, consequently, the use of VO in aquaculture
has reduced the level of n-3 LC-PUFA in feeds with subsequent
impacts on the levels of these nutrients in farmed fish(18,23).
In contrast, VO can be rich sources of C18 PUFA including
both α-linolenic acid (ALA; 18 : 3n-3) and linoleic acid
(LA; 18 : 2n-6)(27). Atlantic salmon possesses all the genes/
enzymes required for the endogenous biosynthesis of both
EPA and DHA from ALA(28,29). Specifically, salmon have been
shown to have fads2 genes, coding for distinct desaturase pro-
teins with separateΔ6 andΔ5 activities, and fatty acyl elongase
5 (elovl5) that are necessary for the production of EPA from
ALA(30–32). Δ-6 fatty acyl desaturase (fads2d6) along with fatty
acyl elongase 2 (elovl2) and/or fatty acyl elongase 4 (elovl4)
that are also present enables the production of DHA from
EPA(33,34). LA competes with ALA for the LC-PUFA biosynthesis
pathway enzymes leading to the production n-6 LC-PUFA,
particularly ARA(19). Although several studies have measured
LC-PUFA biosynthesis in salmon fed diets with varying ALA
and LA levels(35–38), the precise impact of competing dietary
LA and the dietary ALA:LA ratio on the endogenous production
of EPA and/or DHA has not been quantified in Atlantic salmon.
The primary aims of the present study were to quantify the
endogenous production of EPA and DHA from ALA in salmon
fed from first feeding on diets that contain no EPA and DHA and




All animal experimentation was conducted in compliance with
the Animals Scientific Procedures Act 1986 (Home Office
Code of Practice. HMSO: London January 1997) and in accor-
dance with European Union (EU) regulation (EC Directive 86/
609/EEC). The feeding trial was carried out in accordance with
Norwegian national legislation via the Norwegian Animal
Welfare Act (LOV-2015-06-09-19-65) Regulations on the Use
of Animals in Experiments (FOR-2017-04-05-451) that was
amended to implement the requirements contained in the EU
regulations for the use of animals in scientific experimentation
(Directive 2010/63/EU). Norway fully implemented the EU
Directive within its legislature on 1 August 2016 via the
European Economic Area Agreement. In addition, all experi-
mentation performed by the Institute of Aquaculture,
University of Stirling (UoS), is subjected to thorough ethical
review carried out by the UoS Animal Welfare and Ethical
Review Board (AWERB) prior to any work being approved.
This involves all projects, irrespective of where they are carried
out, to be submitted to AWERB for approval using detailed
ethical approval forms that require all aspects of the experimen-
tation to be described including all animal health and welfare
issues as well as other ethical considerations. The present
researchwas assessed by the UoS AWERB and passed the ethical
review process of the UoS.
Fish, diets and feeding trial
A triplicated feeding trial was run in Atlantic salmon (Salmo
salar) from first feeding (initial weight approximately 0·18 g)
for 22 weeks at the Institute of Marine Research (IMR, Matre
Research Station). About 3000 Atlantic salmon eggs were
sourced (Aquagen) and transferred to IMR, Matre, where the
eggs were hatched and alevins maintained under standard rear-
ing conditions. A series of three isoenergetic (digestible energy,
DE= 18 MJ·kg) and isoproteic (digestible protein, DP= 49 %;
DP:DE, 27) diets were formulated and manufactured at the
UoS (Table 1). The FM and FO-free diets (diets A – C) contained
15 % lipid that was supplied by linseed and sunflower oils to pro-
vide three different ALA:LA ratios of approximately 3:1 (A),
1:1 (B) and 1:3 (C). The dry ingredients were ground, mixedwith
oil and water and pelleted using a screw press cold extruder
(DollyTM; Imperia & Monferrina S.p.A). Each diet was prepared
as two batches of the same formulation, processed through
either a 1 or 2 mm die. After drying overnight at 40°C, the feeds
were ground and sieved to produce pellet sizes of 0·5 – 0·8,
0·8 – 1·0, 1·0 – 1·5 and 1·5 – 2·0 mm. A further feed (REF) was
included in the feeding trial as a reference to provide commercial
context. The REF feed was a standard commercial feed used in
the facility for rearing Atlantic salmon parr and contained
primarily FM and FO. The analysed fatty acid compositions of
all four feeds used in the trial are shown in Fig. 1. Analysed
ALA:LA ratioswere 2·61, 0·95 and 0·36 in diets A, B and C, respec-
tively. Prior to first feeding the alevins/fry were distributed into
four tanks (1 × 1 m) supplied with aerated freshwater with
750 fish per tank. In consideration of the fact that the experimen-
tal diets were FM and FO-free, first feeding was performed in the
single replicate tanks with higher fish density to ensure a good
feeding response. During this initial 3-week phase, feeds were
provided by hand, so that the feeding behaviour could be
observed. At approximately 0·5 g, fish from each single tank
were redistributed into 3× 1mdiameter tanks (500 litres volume;
twelve tanks in total) in a freshwater through flow system with
200 alevins/fry per tank at a water temperature of 13°C and
24:0 light:dark. Fishwere fed to excess by automatic feeders with
pellet size increasing as the fish size increased.
Sampling
At distribution of fish into tanks prior to first feeding, a triplicate
sample of 50–60 alevins (approximately 10 g wet weight)
were killed by anaesthetic overdose (tricaine methanesulfonate,
MS-222; 400 mg/l in hydrogen carbonate-buffered solution)
prior to being bulk weighed on an electronic top-loading
balance to 0·1 g accuracy. The initial samples for compositional
analyses were immediately frozen in liquid N2 and stored at –70°C
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prior to analyses. At the end of the trial after 22 weeks feeding,
forty fish per tank were killed by anaesthetic overdose as above
prior to being individually weighed on an electronic top-loading
balance to 0·1 g accuracy. Twenty whole fish per tank were
collected as two pooled samples of ten fish and immediately
frozen in liquid N2 and stored at –70°C prior to analyses.
Another ten fish per tankwere sampled for tissues as two pooled
samples of five fishwith samples immediately frozen in liquidN2.
Tissues collected were liver, intestine, flesh, gill, brain and eye.
A further ten fish per tank were killed as above and liver
collected into RNAlaterTM as 120 individual samples. These
samples were stored overnight at 4°C before freezing at –70°C
prior to RNA extraction and analysis of gene expression.
Lipid and fatty acid analyses
Total lipid was extracted from feeds, whole fish and fish
tissues by homogenising in chloroform–methanol (2:1, v/v)
using an Ultra-Turrax tissue disrupter (Fisher Scientific) and
content determined gravimetrically(39). Total lipids were
resuspended in chloroform–methanol (2:1, v/v) at a concentra-
tion of 10 mg/ml. Total phospholipids (PL) and TAG were
prepared from total lipid by TLC on silica gel sixty plates
(20 × 20 cm; Merck KgaA) and developed to full distance with
isohexane–diethyl ether–acetic acid (85:15:1, by vol.)(40).
Lipid classes were visualised by spraying with 0·1 % (w/v)
2-7-dichlorofluorescein in 97 % aqueous methanol (v/v) and
viewing under UV light at 240 nm (UVP® Mineralight®
R-52G; UVP Inc.). Identified classes (TAG and total PL/origin)
were scraped into glass tubes and lipids eluted with isohexane–
diethyl ether (1:1, v/v). Fatty acid methyl esters (FAME) were
prepared from total lipid, total PL and TAG by acid-catalysed
transesterification at 50°C for 16 h(41), and FAME extracted
and purified as described previously(42). FAME were separated
and quantified by GLC using a Fisons GC-8160 (Thermo
Scientific) equipped with a 30 m × 0·32 mm internal diameter
× 0·25 μm ZB-wax column (Phenomenex), on-column injector
and a flame ionisation detector. H2 was used as carrier gas with
the initial oven thermal gradient from 50°C to 150°C at 40°C/
min to a final temperature of 230°C at 2°C/min. Individual
FAME were identified by comparison with known standards
(Restek 20-FAME Marine Oil Standard; Thames Restek UK
Ltd) and published data(42). The data were collected and proc-
essed using Chromcard for Windows (version 1.19;
Thermoquest Italia S.p.A.).
The within-assay precision of this test is based on six repli-
cates of the same sample, prepared and analysed at the same
time on the same instrumentation, and found to be no greater
than 5 % relative standard deviation (RSD) across the twelve
main fatty acids of interest. In case of a difference of >5 %
RSD between the within-assay replicates, the analysis is
repeated. Between-assay precision is based on six separate
analyses of the same sample at separate time points and the dif-
ference across twelve fatty acids found to be no greater than
5 % RSD.
Liver gene expression
Total RNAwas extracted from individual liver samples of ten fish
per tank by homogenising in 1 ml of TriReagent® following the
producer’s protocol (Sigma-Aldrich). The quantity and quality of
RNA were determined by spectrophotometry (Nanodrop
ND-1000; Labtech Int.) and RNA integrity assessed by agarose
gel electrophoresis. Complementary DNA (cDNA) was synthes-
ised using a high-capacity reverse transcription (RT) kit utilising
2 μg of total RNA and random primers in a total reaction volume
of 20 μl following the manufacturer’s protocol (Applied
Biosystems). The samples were pooled (two samples of five fish
per tank) to obtain n 6 per dietary treatment. A dilution of 1:20
was applied to the resulting cDNA using milliQ water.
Expression levels of key genes involved in LC-PUFA
biosynthesis pathways (fads2d6; fads2d5, Δ-5 fatty acyl desa-
turase; elovl2, fatty acyl elongase 2; elovl5a, fatty acyl
elongase 5 isoform a; elovl5b, fatty acyl elongase 5 isoformb), lipid
biosynthesis (srebp1, sterol regulatory element-binding protein 1;
srebp2, sterol regulatory element-binding protein 2; lxr, liver X
receptor; fas, fatty acid synthase; hmgcr, 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMGCoA) reductase) and lipid catabo-
lism (ppara, peroxisome proliferator-activated receptor α; pparg,
peroxisome proliferator-activated receptor γ; aco, acyl CoA oxi-
dase; cpt1, carnitine palmitoyl transferase 1) were determined
by real-time quantitative RT-PCR in liver, as described in detail
previously(43) (primers as detailed in online Supplementary
Table S1). Results were normalised using reference genes,
hypoxanthine guanine phosphoribosyl transferase (hprt), elon-
gation factor 1 α (ef1α) and TATA box binding protein (tbp) that




Soya protein concentrate* 200·0 200·0 200·0
Soya protein isolate* 200·0 200·0 200·0
Wheat gluten* 200·0 200·0 200·0
Hydrolysate‡ 20·0 20·0 20·0
Casein† 17·0 17·0 17·0
Linseed oil§ 134·0 90·0 44·0
Sunflower oil|| 0·0 44·0 90·0
Cellulose¶ 77·0 77·0 77·0
Pregelled starch** 70·0 70·0 70·0
Crystalline amino acids†† 26·0 26·0 26·0
Premix‡‡ 5·0 5·0 5·0
CaHPO4* 50·0 50·0 50·0
Yttrium oxide§§ 1·0 1·0 1·0
Proximate composition (% dry weight)
Crude protein 50·8 49·5 50·5
Digestible protein 48·9 48·9 48·9
Crude lipid 15·7 15·5 13·8
Ash 7·3 7·1 7·8
Moisture 5·6 5·7 4·0
Digestible energy 18·0 18·1 18·1
* BioMar Ltd.
† Bulk Powders Ltd.
‡ HP1 from Aquativ.
§ Cold-pressed, AniForte UK Ltd.
|| Sainsbury’s Supermarkets Ltd.
¶ Microcrystalline cellulose, Blackburn Distributions Ltd.
** Sigma Pharmaceuticals.
†† Includes methionine (10), lysine (10), taurine (5) and also choline (1).
‡‡ OVN Salmonid from DSM Nutritional Products.
§§ Stanford Materials.
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were shown as the most stable according to GeNorm(44) stabil-
ity number (M = 0·239 for ef1α and 0·213 for both hprt and tbp).
Primers were designed using primer 3 and were previously
tested for efficiency, which was always over 0·80(45).
Quantitative PCR was performed using a Biometra TOptical
Thermocycler (Analytik Jena) in ninety-six well plates in dupli-
cate 20 μl reaction volumes containing 10 μl of Luminaris Color
HiGreen quantitative PCR (qPCR) Master Mix (Thermo
Scientific), 1 μl of primer corresponding to the analysed gene
(10 pmol), 3 μl of molecular biology grade water and 5 μl of
cDNA, with the exception of the reference genes, which were
determined using 2 μl of cDNA. In addition, amplifications were
carried out with a systematic negative control (no template con-
trol) containing no cDNA. Standard amplification parameters
contained a DNase pre-treatment at 50°C for 2 min, an initial
activation step at 95°C for 10 min, followed by thirty-five
cycles: 15 s at 95°C, 30 s at the annealing Tm and 30 s at 72°C.
Statistical analyses
Based on extensive prior experience, the hypothesised effect
sizes of phenomic and transcriptomic responses were expected
to be >1·5 × SD. Using this basis, the experimental power of the
design was calculated post hoc using the ‘ANOVA fixed effects’
test within the G-Power software (http://www.gpower.hhu.de/).
Using an α value of 0·05, an average effect size of approximately
1·5× SD was applied for key response variables (e.g. growth, net
LC-PUFAgain and Log2FC). As an example, a power level (1 – β) of
0·618was determined for growth among diets A, B and C,whereas
the effect sizes of other parameters were larger (e.g. net LC-PUFA
gain had a power level (1 – β) of 0·999).
For biochemical analyses, mean values were calculated for
each tank prior to statistical analyses (n 3). Significance of
differences was determined by one-way ANOVA followedwhen
appropriate by Tukey’s post hoc test using GraphPad InStat,
version 3.01 32 bit for Win95/NT (GraphPad Software Inc.).
For gene expression (n 6), the relative expression levels (gene
expression fold change) of the target genes, normalised to the
three housekeeping genes, were calculated following the
method described by Pfaffl(46). Data were tested for normality
and homogeneity of variances with Levene’s test prior to one-
way ANOVA followed by Tukey’s post hoc test. The statistical
analyses were performed using SPSS software (IBM SPSS
Statistics 23; SPSS Inc.).
Results
After 22 weeks, salmon fed the diets with essentially no EPA and
DHA were less than half the weight of fish fed the reference diet
containing FO (Fig. 2). Although the fish fed the highest content
of LA had the lowest weight, there was no significant effect of
ALA:LA ratio on growth after 22 weeks. Mortality after the initial
feeding phase was very low throughout the trial and unrelated
to feed.
The aim of the present study was to very specifically quantify



























































































A (3:1) B (1:1) C (1:3)
Fig. 2. Final weights (g) of salmon after feeding the experimental and reference
(REF) diets for 22 weeks (154 d). Data aremeans (n 3), with standard deviations
represented by vertical bars. a,b Mean values with unlike letters were
significantly different between diets (determined by ANOVA followed by
Tukey’s multiple comparison test).
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overall desaturation of ALA (and LA). Although 20 : 4n-3 satisfies
our definition of LC-PUFA (≥C20 and ≥3 double bonds), it was
not included in the calculations for total LC-PUFA production in
the present study. Similarly, 18 : 3n-6 and 20 : 3n-6 were not
included in the data for total n-6 LC-PUFA production.
However, docosapentaenoic acid (DPA, 22 : 5n-3) was included
along with EPA and DHA in total n-3 LC-PUFA, and 22 : 4n-6 and
22 : 5n-6 were included along with ARA in total n-6 PUFA (Fig. 3
and 4). Full fatty acid compositions of whole fish after 22 weeks
of being fed diets containing essentially no EPA and DHA are
presented in online Supplementary Table S2.
Salmon fed diets with ALA:LA ratios of 3:1, 1:1 and 1:3
contained 107, 80 and 41 mg of total n-3 LC-PUFA (EPA þ
DPA þ DHA) per fish, almost all of which were the result of
endogenous production as initial first feeding fry contained just
under 1 mg total n-3 LC-PUFA per fish (Fig. 3). In the initial fry,
DHA and EPAwere present with a ratio of 2:1, whereas in fry fed
an ALA:LA ratio of 3:1 DHA and EPAwere in a ratio of over 2·6:1.
This contrasted with the fish fed a standard commercial feed
containing EPA and DHA, where they accumulated 757 mg
of total n-3 LC-PUFA, with DHA and EPA in a ratio of 3·2:1
(Fig. 4). Fry fed the highest amount of LA (ALA:LA of 1:3)
accumulated 21 mg n-6 LC-PUFA, which compared with just
over 28 mg in fish fed standard commercial feed, while initial
fry contained only 0·07 mg of ARA (Fig. 5).
On a per fish basis, endogenous production of n-3 LC-PUFA
was at least 5·9, 4·4 and 2·8 mg/g fish, and that of n-6 LC-PUFA
was at least 0·2, 0·5 and 1·4 mg/g fish in salmon fed diets with
ALA:LA ratios of 3:1, 1:1 and 1:3, respectively (Fig. 6). As daily
(154 d trial) rates of production, these data corresponded to at
least 38·1, 28·4 and 18·2 μg/g fish per d for endogenous
production of n-3 LC-PUFA, and at least 1·4, 3·4 and 9·3 μg/g
fish per d for n-6 LC-PUFA production in salmon fed diets with
Fig. 3. n-3 Long-chain PUFA (LC-PUFA) contents (mg/fish) of fry at first feed-
ing/initiation of the trial (Initial) andwhole fish after feeding the experimental diets
for 22weeks (Final). Data aremeans (n 3), with standard deviations represented
by vertical bars. a,b,c,d Mean values for each fatty acid with unlike letters were
significantly different between diets (determined by ANOVA followed by
Tukey’s multiple comparison test). , 20 : 5n-3; , 22 : 5n-3; , 22 : 6n-3;
, total n-3 LC-PUFA.
Fig. 4. n-3 Long-chain PUFA (LC-PUFA) contents (mg/fish) of whole fish fed the
experimental diets (A, B and C) in comparison with fish fed the reference diet
(REF) for 22 weeks. Data aremeans (n 3), with standard deviations represented
by vertical bars. a,b,c,d Mean values for each fatty acid with unlike letters were
significantly different between diets (determined by ANOVA followed by
Tukey’s multiple comparison test). , 20 : 5n-3; , 22 : 5n-3; , 22 : 6n-3;
, total n-3 LC-PUFA.
Fig. 5. n-6 Long-chain PUFA (LC-PUFA) contents (mg/fish) of fry at first feed-
ing/initiation of the trial (Initial) andwhole fish after feeding the experimental diets
for 22 weeks (Final). a,b,c,d,e Mean values for each fatty acid with unlike letters
were significantly different between diets (determined by ANOVA followed by
Tukey’s multiple comparison test). , 20 : 4n-6; , 22 : 4n-6; , 22 : 5n-6;
, total n-6 LC-PUFA.
Fig. 6. Production of n-3 and n-6 long-chain PUFA (LC-PUFA) (mg/g fish)
and n-3 LC-PUFA:n-6 LC-PUFA, DHA:EPA, EPA:arachidonic acid (ARA) and
DHA:ARA ratios in whole fish after feeding the experimental diets (A ( ; 3:1),
B ( ; 1:1) and C ( ; 1:3)) for 22 weeks. Data are means (n 3), with standard
deviations represented by vertical bars. a,b,c Mean values for each parameter
with unlike letters were significantly different between diets (determined by
ANOVA followed by Tukey’s multiple comparison test).
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ALA:LA ratios of 3:1, 1:1 and 1:3, respectively. The ratio of n-3
LC-PUFA production ton-6 LC-PUFA production decreased from
27·4 to 2·0 as dietary ALA:LA ratio decreased and, similarly,
EPA:ARA and DHA:ARA ratios decreased as the dietary ratio
of ALA:LA decreased. Less obviously, and more interestingly,
the DHA:EPA ratio increased from 2·6 to 5·3 as the dietary ratio
of ALA:LA decreased (Fig. 6).
The distribution of the endogenously produced LC-PUFA in
specific lipid classes and tissues was also investigated.
Comparing the proportion of fatty acids in total lipid and
lipid classes, the percentages of n-3 LC-PUFA and n-6 PUFA
were higher in total PL than in TAG (Fig. 7). To compare the
distribution among tissues, the level of the particular fatty acid
(DHA, EPA and ARA) in whole fish was compared with the
levels in individual tissues. Setting the reference level as the
amount of n-3 LC-PUFA in whole fish fed the diet containing
ALA:LA at 3:1 (highest production), DHA was present at far
higher levels in brain and also, to a lesser extent, in liver
(Fig. 8). In contrast, EPA was present in higher amounts in liver
and, to a lesser extent, in brain. With ARA, only liver showed a
higher level than the reference, which was set as the level in
whole fish fed the diet containing ALA:LA at 1:3 (highest ARA
production) (Fig. 8).
Determination of the expression of key genes of LC-PUFA
biosynthesis in liver by quantitative RT-PCR showed that tran-
script abundances of fads2d6 and fads2d5 and elovl2 were all
significantly higher in fish fed the experimental feeds lacking
LC-PUFA (Fig. 8). Although the differences were not statistically
significant, expression levels of these genes were numerically
lower in fish fed the diet balanced (equal proportions) with
ALA and LA. In contrast, diet did not affect the expression
of elovl5a and slightly reduced the expression of elovl5b
(Fig. 9). The expression of some genes related to lipid anabolic
pathways, srebp1, srebp2 and fas showed increasing expres-
sion with increasing dietary LA (i.e. as ALA:LA decreased),
while some genes related to lipid catabolism, ppara, pparg
Fig. 7. Long-chain PUFA (LC-PUFA) composition (percentage of total fatty acids) of whole fish total lipid (TL; ), phospholipids (PL; ) and TAG ( ). Data are means
(n 3), with standard deviations represented by vertical bars. a,b,c,d Mean values for each parameter with unlike letters were significantly different between diets in contents
in TL, PL and TAG (determined by ANOVA followed by Tukey’s multiple comparison test). Total, total n-3 LC-PUFA (upper panel) and total n-6 LC-PUFA (lower panel);
ARA, arachidonic acid.
Fig. 8. Tissue contents (mg fatty acid/100 g of whole fish or tissue) of EPA, DHA
and arachidonic acid (ARA) after feeding the experimental diets (A ( ; 3:1),
B ( ; 1:1) and C ( ; 1:3)). Data are means (n 3), with standard deviations rep-
resented by vertical bars. a,b,c Mean values with unlike letters for each tissue
were significantly different between diets (ANOVA followed by Tukey’s multiple
comparison test). The dotted lines in the upper and middle panels represent the
EPA andDHA contents, respectively, of whole fish in fish fed diet A that gave the
highest production of EPAandDHA. Similarly, the dotted line in the bottom panel
represents the ARA content of whole fish in fish fed diet C that gave the highest
production of ARA.
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and aco, showed the same pattern of expression among the
three experimental feeds, with the lowest expression in fish
fed the diet with an ALA:LA ratio of 1 (Fig. 9).
Discussion
Although the fish fed the low ALA:LA ratio had the numerically
lowest final weight, no significant differences were found
between fish fed the experimental diets, indicating that the
dietary n-3 PUFA:n-6 PUFA ratio had little impact on growth.
Of course, the fish fed the FM- and FO-free feeds were signifi-
cantly smaller than fish fed the REF feed, which was entirely
expected. The REF feed was not a control feed in the present
study, but simply a reference to place some of the data obtained
into context. It has already been demonstrated that salmon
post-smolts can be grown on essentially FM and FO-free feeds
without major impacts on growth using highly optimised
feeds(47,48). This was not the aim of the present trial, which
was not a nutritional trial in terms of growth and feed efficiency
and was not testing ingredients but was focused entirely on
nutrients and, specifically, LC-PUFA. The experimental feeds
were therefore formulated to supply nutrients at currently
reported requirement levels for Atlantic salmon(49). In this
respect, it is also important to clarify that the experimental feeds
were not essential fatty acid (EFA)-deficient despite containing
no EPA, DHA or ARA, as ALA and LA are reported to satisfy EFA
requirements in salmonids (with complete LC-PUFA biosynthe-
sis pathways) and the feeds contained ALA and LA at levels far
above the reported requirement levels(49). Certainly, the fish
fed the experimental feeds showed none of the classical
EFA-deficiency signs(50). However, it is also known that
LC-PUFA can supply EFA requirements at lower levels and
so the lack of LC-PUFA may indeed be part of the reason for
the lower growth obtained(51,52). However, the commercial start
feed, as with the feeds used in the FM- and FO-free studies
above, would undoubtedly be supplying many nutrients in
excess of the minimal levels reported by the National
Research Council(49). Thus, it was expected that the experimen-
tal feeds would impact growth and, hence, the reason to
include the commercial feed (REF) to provide some context.
Growth rate is linked to metabolic activity including intermedi-
ary metabolism and key anabolic pathways such as LC-PUFA
biosynthesis and, therefore, differences in growth rate could
affect production rates per fish. However, growth rate is less
likely to affect production per gram of fish, and so data pre-
sented this way should be unaffected by the differences in
growth rate.
It had been shown previously that salmonids, Atlantic
salmon and rainbow trout (Oncorhynchus mykiss) can be net
producers of n-3 LC-PUFA by feeding diets with only low levels
of FO(53,54). While no method for assessing in vivo production
of LC-PUFA is perfect(55), production of EPA and DHA in these
studies was calculated from total fatty acid intakes and final
Fig. 9. Relative expression of genes of long-chain PUFA biosynthesis (upper panel), lipid anabolism (middle panel) and lipid catabolism (bottom panel) in liver of Atlantic
salmon as determined by quantitative PCR. Results are normalised expression ratios. Data are means (n 6), with standard errors represented by vertical bars. a,b Mean
valueswith unlike letters for each genewere significantly different between diets (one-way ANOVA). aco, Acyl coAoxidase; cpt1, carnitine palmitoyl transferase 1; elovl2,
fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty acyl elongase 5 isoform b; fads2d5, Δ-5 fatty acyl desaturase; fads2d6, Δ-6 fatty acyl desa-
turase; fas, fatty acid synthase; hmgcr, 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMGCoA) reductase; lxr, liver X receptor; ppara, peroxisome proliferator-activated
receptor α; pparg, peroxisome proliferator activated receptor γ; srebp1, sterol regulatory element-binding protein 1; srebp2, sterol regulatory element-binding protein 2.
, Reference diet; , diet A; , diet B; , diet C.
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fatty acid contents in whole fish using ‘fatty acid production
value, FAVP’(56) or the whole body mass balance method(57).
The present study used essentially similar methodology to
these earlier studies except that the feeds were fed from first
feeding and contained essentially no LC-PUFA. This simplified
the calculations as, other than the very small amount of EPA,
DHA and ARA in the alevins at first feeding, all the LC-PUFA
present in the fish at the end of the trial were derived from
endogenous biosynthesis. Feeding diets with no EPA and
DHA from first feeding had been done previously with
rainbow trout, but quantitative LC-PUFA production was not
reported(58).
The present study showed that in the trial period Atlantic
salmon produced almost 6 mg n-3 LC-PUFA from ALA per
gram of fish (approximately 40 μg/g fish per d). There are
some caveats to this figure. First, it should be regarded as a
minimum amount and cannot be lower, as it is highly likely
that some LC-PUFA produced will be oxidised as demon-
strated previously(54,57,59). While endogenously produced
LC-PUFA may be less oxidised than dietary fatty acids, there
is no biochemical/physiological mechanism to prevent this
oxidation(60). Second, the data are limited to fry and the first
half of the parr (freshwater) stage and this could change over
the entire life cycle. Biosynthesis of LC-PUFA from 14C-ALA
was increased in hepatocytes of salmon undergoing parr–
smolt transformation(61,62) and, therefore, this could increase
the capacity for endogenous production. Therefore, existing
data suggest 6 mg/g fish is minimum for production during
the freshwater stage, which may increase prior to seawater
transfer. There are few data on how the capacity for
LC-PUFA biosynthesis is affected by age per se and, indeed,
this is identified as a gap in the knowledge for humans(63).
However, there is evidence that the capacity for conversion
of ALA to DHA is higher in human infants than in adults(64).
In salmon, based on assays of LC-PUFA production in hepa-
tocytes, it has been speculated that activity may be lower in
post-smolts in seawater(61,62), but there are no in vivo studies
to directly support this.
In humans, in vivo conversion of ALA to n-3 LC-PUFA has
been estimated in a number of studies including stable isotope
studies and is generally very modest, with some low conversion
to EPA with conversion to DHA being even lower or not at
all(63,65,66). In fish, there are no previous studies that provide
equivalent data with which to directly compare the present
results. However, in an in vivo stable isotope study using
4–15 g rainbow trout fed 5 % FM and 11 % VO, the rate of
DHA production was reported to be low at 0·54 μg/g fish per
mg ALA consumed per d(67). This estimate is not directly
comparable to the rate calculated in the present study.
Extrapolating from data calculated via thewhole body fatty acid
mass balance method, total ALA conversion could be
estimated at about 1·5 μg/g fish per d when the rainbow trout
were fed a high ALA diet(68). While the methodology used in the
earlier trout trial was somewhat similar to that used in the
present study, the data are not directly comparable as the diets
were formulated with FM and contained approximately 1·5 %
n-3 LC-PUFA (EPA:DHA approximately 1), and the presence
of dietary DHA would reduce Δ6 desaturation of ALA(69,70).
In humans, reducing dietary LA (increasing ALA:LA ratio)
enabled increased conversion of ALA to EPA and, in some cases,
also increased DHA(63,66). The present study demonstrated how
the dietary ALA:LA ratio quantitatively impacted the overall pro-
duction of both n-3 and n-6 LC-PUFA in salmon. Thus, irrespec-
tive of dietary ALA:LA ratio, n-3 LC-PUFA production always
exceeded n-6 LC-PUFA production, being 27-fold greater when
dietary ALA exceeded LA by 2·6-fold, and it was still 2-fold
greater when fish were fed a diet with a 2·6-fold excess of LA.
This demonstrates clearly the preferences of enzymes in the
LC-PUFA biosynthesis pathway for n-3 compared with n-6 fatty
acid substrates, confirming the results from studies on enzyme
activities determined with radiolabelled tracers in hepato-
cytes(61), preferences of individual desaturase and elongase
proteins in heterologous expression assays(71), and by the
whole-bodymass balancemethod(72). While there are numerous
studies investigating the effects of dietary ALA:LA ratio in fish,
few have attempted to quantify impacts on LC-PUFA production.
However, increasing dietary LA reduced n-3 LC-PUFA produc-
tion and increased n-6 LC-PUFA production in Murray cod
(Maccullochella peelii peelii)(72). In contrast, while increasing
dietary LA had a significant impact on increasing n-6 LC-PUFA
production in rainbow trout, it only marginally impacted n-3
LC-PUFA production(68), reducing EPA production but with little
effect on DHA production(73). A further noteworthy result in the
present study was that increased dietary LA (reduced ALA:LA
ratio) also resulted in a reduction in the overall LC-PUFA produc-
tion. The overall rate of LC-PUFA production decreased from
approximately 39·5 μg/g fish per d (38·1 n-3 þ 1·4 n-6) in fish
fed the high ALA:LA ratio to approximately 27·5 μg/g fish per
d (18·2þ 9·3) in fish fed the lowALA:LA ratio; and therefore, high
dietary LA in effect inhibited the pathway. In contrast, this was
not observed in rainbow trout, where the total LC-PUFA produc-
tion was largely unaffected by ALA:LA ratio(68). Extrapolating
from whole-body fatty acid mass balance data, approximately
1·6 μg/g fish per d (1·5 ALA þ 0·1 LA) to approximately
1·7 μg/g fish per d (1·4 þ 0·3) of C18 PUFA were converted into
fish fed diets with high and low ALA:LA ratio, respectively(68).
The optimal dietary DHA:EPA ratio and its relationship to
tissue DHA:EPA ratios present a complicated situation and are
poorly understood in salmon or, indeed, any species(59,74).
The present study aimed to provide some insight to the optimal
dietary ratio of DHA:EPA by extrapolating from the ratio actually
produced endogenously in salmon when receiving no dietary
input of preformed EPA andDHA. One initial point to note is that
the level of DHA in whole fish always exceeded that of EPA, so
the DHA:EPA ratio was always >1 in the present study. This was
also the case in the earlier study in rainbow trout fed a diet com-
pletely devoid of EPA and DHA (and an ALA:LA ratio of about 1),
where DHA:EPA ratio in both polar and neutral lipids in carcass,
liver and intestine varied between 1·3 in carcass neutral lipid and
4·1 in liver polar lipids(58). However, interestingly, the present
study demonstrated that the DHA:EPA ratio produced through
endogenous production of EPA and DHA was not fixed but
affected by the dietary ALA:LA ratio; and thus, as dietary LA
increased, the DHA:EPA ratio also increased. While this is
not something that had been highlighted previously, careful
examination of existing literature has shown that increased
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dietary LA (i.e. reduced ALA:LA ratio) generally resulted in
increased DHA:EPA ratios in whole fish and/or tissues of a
range of freshwater and salmonid species(68,73,75–81), though
not always(72,82,83). It must be stressed that the above results
are not directly comparable with the present study as the fish
in these earlier trials were all fed diets that also contained
EPA and DHA, complicating interpretation of the data.
However, a likely possible mechanism for the impact of dietary
LA on DHA:EPA ratio is that increased LA would increase com-
petition with ALA for the LC-PUFA pathway (Δ6 desaturase)
and this could particularly impact the production of EPA, but
not the production of DHA from EPA to the same extent.
This explanation reflects the chemistry/biochemistry and
enzyme kinetics of the biosynthesis pathways in salmon(60,71),
but an alternative explanation is that the result could possibly
reflect a physiological driver with DHA being ‘more essential’
than EPA for membrane structure and function(59). In rats,
the DHA:EPA ratio is highly dependent upon tissue with
EPA > DHA in blood and liver, but DHA greatly exceeding
EPA in heart and brain, and dietary ALA and ALA:LA ratio
(no dietary EPA and DHA) had relatively little impact on tissue
DHA:EPA ratios(84).
While the above discussed quantitative and semi-quantitative
data were the primary focus, the present study also provided
some additional insight into the fates of endogenously
produced LC-PUFA. Irrespective of diet, the relative propor-
tions of total LC-PUFA, EPA, DHA and ARA were all higher in
total PL than in TAG as would be expected(60). However, this
pattern was greatly enhanced in fish fed the experimental feeds
comparedwith fish fed the reference diet, clearly indicating that
endogenously produced EPA, DHA and ARA were highly
preferentially incorporated into membrane PL, whereas greater
proportions of dietary LC-PUFA are deposited in storage lipid.
To discriminate tissue preferences for the deposition of
endogenously produced LC-PUFA, we compared the contents
of individual tissueswith the content inwhole fish. Thus, tissues
showing higher contents per unit mass than whole fish indicate
preferential deposition. This was clearly observed in the high
DHA content of brain, which reflected the known importance
of DHA in that tissue(60). The only other tissue that showed
higher contents of LC-PUFA was liver, probably reflecting its
key metabolic role in biosynthesis(28,60). Gene expression con-
firmed the active role of liver in the biosynthesis of LC-PUFA
with the expression of fads2d6 and fads2d5 and elovl2 all being
up-regulated in fish fed the experimental feeds devoid of
EPA and DHA, consistent with many previous studies in
salmon(32,71). However, dietary ALA:LA ratio appeared to have
little effect, suggesting that substrate levels were not a major
driver of expression of these genes(38). Similarly, there was
no effect of dietary ALA:LA ratio on the expression of Δ6
desaturase and elovl5 in liver of rainbow trout(68). Dietary
ALA:LA ratio affected the expression of Δ6 and Δ4 desaturases
and elovl5 in the marine rabbit fish (Siganus canaliculatus),
which has all the genes necessary for biosynthesis of EPA
and DHA, but in a variable manner with no clear pattern(81).
Interestingly, in the present study, brain showed relatively high
contents of EPA in addition to DHA, which may indicate in situ
production of DHA in brain. However, it is not possible to
discriminate what proportion, if any, of brain DHA is actually
the result of in-tissue production or simply deposition of
DHA produced elsewhere, such as liver(28,60). Furthermore,
the fact that the high content of DHA in brain was not reflected
in ARA content of brain was surprising(60).
The increased expression of the lipid anabolic genes, sreb1,
sreb2 and fas, as dietary ALA:LA decreased was also
unexpected. It is worth noting that the effect of diet on gene
expression can be looked at in two ways. Either that high
dietary ALA and high ALA:LA ratio resulted in lower expression
or that high dietary LA and low ALA:LA ratio increased
expression. Irrespective, the dietary effect does not have an
obvious biochemical or physiological explanation. Similarly,
while it was also interesting that genes related to lipid catabo-
lism, ppara, pparg and aco, all showed a similar pattern of
expression among the three experimental feeds, with lowest
expression at a dietary ALA:LA ratio of 1, the pattern was not
readily explained. While it is perhaps noteworthy that the
expression of the fads2d6 and fads2d5 and elovl2 also showed
the same expression pattern as for the lipid catabolism genes,
it does not offer an explanation. Therefore, the precise mech-
anism(s) underlying how dietary ALA:LA ratio affected the
expression of lipid anabolic and catabolic genes was not clear
and requires further study.
The data obtained in the present study have provided a
better understanding of the capacity for LC-PUFA production
in a vertebrate, Atlantic salmon, that has a complete biosyn-
thetic pathway (via the Sprecher shunt), and how dietary
ALA and LA interact and affect LC-PUFA production. Salmon
farming is currently still largely dependent upon FO for
provision of EPA and DHA, but levels of FO in feeds continue
to decline(85), resulting in reduced levels of EPA in DHA in
farmed salmon products(18). Presently, about 70 % of oil in
salmon feeds is supplied by VO that can only supply C18
PUFA, LA and ALA(27) and, though there are potential new algal
and GM-derived sources of EPA and DHA on the horizon, it is
uncertain exactly how these will be used(86). Currently, cost and
availability restrict the use of these new sources, for the
medium term at least, so that FO replacements maintain EPA
and DHA at current levels, and not as VO replacements and,
therefore, salmon feeds will continue to contain high levels
of VO. However, there are many options with oils containing
differing proportions of ALA and LA, and the data from the
present study enable the possibility to more precisely control
dietary ALA and LA to maximise endogenous production of
EPA and DHA.
Conclusions
With a dietary n-3:n-6 PUFA ratio of 1:1, Atlantic salmon fry/parr
can produce at least 4·4 mg n-3 LC-PUFA, with a DHA:EPA ratio
of 3·4:1, per g fish. Production of n-3 LC-PUFA exceeded that of
n-6 LC-PUFA by almost 9-fold. Reducing the dietary n-3:n-6
PUFA ratio reduced n-3 LC-PUFA production and EPA:ARA
and DHA:ARA ratios, and increased n-6 LC-PUFA production,
and DHA:EPA ratio. The data advance nutritional science by
providing insight into and a clearer understanding of the quan-
titative capacity of the pathway in a vertebrate that has complete
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LC-PUFA biosynthesis pathways (via the Sprecher shunt), and
how dietary ALA and LA interact and quantitatively affect
LC-PUFA production.
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